John J L Jacobs
Overview
Explore the profile of John J L Jacobs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobs J, Beekers I, Verkouter I, Richards L, Vegelien A, Bloemsma L, et al.
PLOS Digit Health
. 2025 Jan;
4(1):e0000464.
PMID: 39787064
Precision, or personalised medicine has advanced requirements for medical data management systems (MedDMSs). MedDMS for precision medicine should be able to process hundreds of parameters from multiple sites, be adaptable...
2.
Haitjema S, Nijman S, Verkouter I, Jacobs J, Asselbergs F, Moons K, et al.
Eur Heart J Digit Health
. 2024 Sep;
5(5):572-581.
PMID: 39318684
Aims: A major challenge of the use of prediction models in clinical care is missing data. Real-time imputation may alleviate this. However, to what extent clinicians accept this solution remains...
3.
Backel N, Hort S, Kis T, Nettleton D, Egan J, Jacobs J, et al.
Front Mol Med
. 2024 Aug;
3:1250508.
PMID: 39086671
This paper discusses the challenges of producing CAR-T cells for cancer treatment and the potential for Artificial Intelligence (AI) for its improvement. CAR-T cell therapy was approved in 2018 as...
4.
Blankestijn J, Baalbaki N, Bazdar S, Beekers I, Beijers R, van den Bergh J, et al.
J Allergy Clin Immunol
. 2024 Jun;
154(3):807-818.
PMID: 38830512
Background: Months after infection with severe acute respiratory syndrome coronavirus 2, at least 10% of patients still experience complaints. Long-COVID (coronavirus disease 2019) is a heterogeneous disease, and clustering efforts...
5.
Blankestijn J, I Abdel-Aziz M, Baalbaki N, Bazdar S, Beekers I, Beijers R, et al.
BMJ Open Respir Res
. 2024 Apr;
11(1).
PMID: 38663887
Background: Four months after SARS-CoV-2 infection, 22%-50% of COVID-19 patients still experience complaints. Long COVID is a heterogeneous disease and finding subtypes could aid in optimising and developing treatment for...
6.
Shevtsova D, Ahmed A, Boot I, Sanges C, Hudecek M, Jacobs J, et al.
JMIR Hum Factors
. 2024 Jan;
11:e47031.
PMID: 38231544
Background: Artificial intelligence (AI)-powered technologies are being increasingly used in almost all fields, including medicine. However, to successfully implement medical AI applications, ensuring trust and acceptance toward such technologies is...
7.
Baalbaki N, Blankestijn J, I Abdel-Aziz M, De Backer J, Bazdar S, Beekers I, et al.
J Pers Med
. 2023 Jul;
13(7).
PMID: 37511673
: The coronavirus disease 2019 (COVID-19) pandemic has led to the death of almost 7 million people, however, with a cumulative incidence of 0.76 billion, most people survive COVID-19. Several...
8.
Nijman S, Hoogland J, Groenhof T, Brandjes M, Jacobs J, Bots M, et al.
Eur Heart J Digit Health
. 2023 Jan;
2(1):154-164.
PMID: 36711167
Aims: Use of prediction models is widely recommended by clinical guidelines, but usually requires complete information on all predictors, which is not always available in daily practice. We aim to...
9.
Hort S, Herbst L, Backel N, Erkens F, Niessing B, Frye M, et al.
Front Med (Lausanne)
. 2022 Jun;
9:913287.
PMID: 35733863
CAR-T cell therapy is a promising treatment for acute leukemia and lymphoma. CAR-T cell therapies take a pioneering role in autologous gene therapy with three EMA-approved products. However, the chance...
10.
Jacobs J
Med Hypotheses
. 2021 Feb;
149:110538.
PMID: 33621843
COVID-19 is a serious disease that has infected more than 40 million people. Beside significant mortality, the SARS-CoV-2 infection causes considerable and sustained morbidity, dubbed long COVID. This paper argues...